AtriCure, Inc.

ATRC ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2025 FY2024 FY2023 FY2009

Total Cash from Operations: $3.9M

Line Item	Value	% of Total
Capital Expenditures	$0	0.0%
Other Financing	$124.4K	3.2%
Working Capital	$3.5M	89.2%
Other	$295.6K	7.6%
Net Cash Flow	$0	0.0%